Cargando…
Blue light transurethral resection and biopsy of bladder cancer with hexaminolevulinate: Histopathological characteristics and recurrence rates in a single UK centre study
INTRODUCTION: Blue light cystoscopy with hexaminolevulinate (HAL) during transurethral resection of bladder cancer (TURBT) has been shown to improve detection, thereby reducing bladder cancer recurrence compared with white light cystoscopy. METHODS: Single‐centred UK (United Kingdom) study on 101 pa...
Autores principales: | Chan, Kimberley, Hampson, Alexander, Hayes, John, Rabinowitz, Joshua, Vasdev, Nikhil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447208/ https://www.ncbi.nlm.nih.gov/pubmed/37636209 http://dx.doi.org/10.1002/bco2.250 |
Ejemplares similares
-
Hexaminolevulinate Blue-Light Cystoscopy in a Patient with Metastatic Melanoma of the Bladder
por: Shukla, Anant, et al.
Publicado: (2016) -
Systematic Review and Meta-Analysis on the Impact of Hexaminolevulinate- Versus White-Light Guided Transurethral Bladder Tumor Resection on Progression in Non-Muscle Invasive Bladder Cancer
por: Gakis, Georgios, et al.
Publicado: (2016) -
The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer – A New Analysis
por: Kamat, Ashish M., et al.
Publicado: (2016) -
Efficacy and Safety of Hexaminolevulinate Fluorescence Cystoscopy in the Diagnosis of Bladder Cancer
por: Lee, Jae Seung, et al.
Publicado: (2012) -
Improving hexaminolevulinate enabled cancer cell detection in liquid biopsy immunosensors
por: Chan, Kit Man, et al.
Publicado: (2021)